Chronic treatment with irinotecan activates the PI3K/Akt/mTOR pathway in HT-29 colon cancer xenografts

被引：0
|
作者：
Souza, K. K. [1 ]
Oliveira, J. C. [1 ]
Dias, M. M. [1 ]
Ropelle, E. R. [1 ]
Rocha, G. Z. [1 ]
Costa, F. O. [1 ]
Carvalheira, J. B. C. [1 ]
机构：
[1] Univ Estadual Campinas, Campinas, SP, Brazil
来源：
EJC SUPPLEMENTS | 2008年 / 6卷 / 09期
关键词：
D O I：
10.1016/S1359-6349(08)71298-9
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
下载
收藏
页码：32 / 32
页数：1
相关论文
共 50 条
  • [21] Targeting PI3K/Akt/mTOR signaling pathway in the treatment of prostate cancer radioresistance
    Chang, Lei
    Graham, Peter H.
    Ni, Jie
    Hao, Jingli
    Bucci, Joseph
    Cozzi, Paul J.
    Li, Yong
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2015, 96 (03) : 507 - 517
  • [22] Targeting PI3K/AKT/mTOR Signaling Pathway in Breast Cancer
    Li, Huayi
    Prever, Lorenzo
    Hirsch, Emilio
    Gulluni, Federico
    CANCERS, 2021, 13 (14)
  • [23] The PI3K/AKT/mTOR pathway in the pathophysiology and treatment of pituitary adenomas
    Monsalves, Eric
    Juraschka, Kyle
    Tateno, Toru
    Agnihotri, Sameer
    Asa, Sylvia L.
    Ezzat, Shereen
    Zadeh, Gelareh
    ENDOCRINE-RELATED CANCER, 2014, 21 (04) : R331 - R344
  • [24] The PI3K/AKT/mTOR Pathway as a Therapeutic Target in Endometrial Cancer
    Slomovitz, Brian M.
    Coleman, Robert L.
    CLINICAL CANCER RESEARCH, 2012, 18 (21) : 5856 - 5864
  • [25] Prospects of targeting PI3K/AKT/mTOR pathway in pancreatic cancer
    Mortazavi, Motahareh
    Moosavi, Fatemeh
    Martini, Miriam
    Giovannetti, Elisa
    Firuzi, Omidreza
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2022, 176
  • [26] Targeting the PI3K/Akt/mTOR Pathway for Breast Cancer Therapy
    Cidado, Justin
    Park, Ben Ho
    JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA, 2012, 17 (3-4) : 205 - 216
  • [27] Vertical inhibition of the PI3K/Akt/mTOR pathway for the treatment of osteoarthritis
    Chen, Jiezhong
    Crawford, Ross
    Xiao, Yin
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2013, 114 (02) : 245 - 249
  • [28] Inhibition of PI3K/AKT/mTOR pathway for the treatment of endometriosis Reply
    Matsuzaki, Sachiko
    Pouly, Jean-Luc
    Canis, Michel
    BRITISH JOURNAL OF PHARMACOLOGY, 2018, 175 (17) : 3628 - 3629
  • [29] Targeting the PI3K/Akt/mTOR pathway for cancer prevention.
    Dennis, PA
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2005, 14 (11) : 2800S - 2801S
  • [30] The PI3K/AKT/mTOR pathway as a therapeutic target in ovarian cancer
    Mabuchi, Seiji
    Kuroda, Hiromasa
    Takahashi, Ryoko
    Sasano, Tomoyuki
    GYNECOLOGIC ONCOLOGY, 2015, 137 (01) : 173 - 179
12345